Zhenhai Lu
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Surgical Treatments
- Cancer Immunotherapy and Biomarkers
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Zhizhong Pan (46 shared papers)Jianhong Peng (33 shared papers)Xiaojun Wu (25 shared papers)Junzhong Lin (22 shared papers)Desen Wan (25 shared papers)Yujing Fang (11 shared papers)Rongxin Zhang (13 shared papers)Qingjian Ou (9 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cancer Communications (3 papers)Chinese Journal of Cancer (3 papers)Journal of Cancer (3 papers)World Journal of Surgical Oncology (2 papers)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Zhenhai Lu
52 papers receiving 1.1k citations
Zhenhai Lu's Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 554
- Hepatology 147
- Cancer Research 273
- Pulmonary and Respiratory Medicine 197
- Immunology 125
Countries citing papers authored by Zhenhai Lu
This map shows the geographic impact of Zhenhai Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenhai Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenhai Lu more than expected).
Fields of papers citing papers by Zhenhai Lu
This network shows the impact of papers produced by Zhenhai Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenhai Lu. The network helps show where Zhenhai Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenhai Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer Hit paper breakdown → | 2023 | 240 |
| 2 | 2018 | 98 | |
| 3 | 2015 | 64 | |
| 4 | 2003 | 46 | |
| 5 | 2021 | 46 | |
| 6 | 2017 | 39 | |
| 7 | 2017 | 36 | |
| 8 | 2013 | 35 | |
| 9 | 2017 | 33 | |
| 10 | 2016 | 32 | |
| 11 | 2018 | 32 | |
| 12 | 2019 | 30 | |
| 13 | 2017 | 30 | |
| 14 | 2010 | 30 | |
| 15 | 2016 | 29 | |
| 16 | 2024 | 26 | |
| 17 | 2017 | 23 | |
| 18 | 2023 | 21 | |
| 19 | 2016 | 17 | |
| 20 | 2018 | 16 |
About Zhenhai Lu
Zhenhai Lu is a scholar working on Oncology, Surgery, Pulmonary and Respiratory Medicine, Hepatology and Pathology and Forensic Medicine, having authored 55 papers that have together received 1.1k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (24 papers), Colorectal Cancer Surgical Treatments (20 papers), Gastric Cancer Management and Outcomes (17 papers), Hepatocellular Carcinoma Treatment and Prognosis (15 papers), Colorectal and Anal Carcinomas (10 papers), Genetic factors in colorectal cancer (8 papers), Colorectal Cancer Screening and Detection (8 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). The work is most often cited by research in Oncology (554 citations), Hepatology (147 citations), Cancer Research (273 citations), Pulmonary and Respiratory Medicine (197 citations) and Immunology (125 citations). Zhenhai Lu has collaborated with scholars based in China, United States and France. Frequent co-authors include Zhizhong Pan, Jianhong Peng, Xiaojun Wu, Junzhong Lin, Desen Wan, Yujing Fang, Rongxin Zhang, Qingjian Ou, Weihao Li and Zhenlin Hou. Their work appears in journals such as Journal of Clinical Oncology, Cancer Communications, Chinese Journal of Cancer, Journal of Cancer and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.